| METHOD FOR CORRECTION OF ERYTHROCYTE PROTEIN AND LIPID STATUS IN ISCHEMIC HEART DISEASE | |
| 2024-06-27 | |
| 专利权人 | UNIV MISIS NAT SCI & TECHNOLOGY (UMNS-C) |
| 申请日期 | 2024-06-27 |
| 专利号 | RU2835301-C1 |
| 成果简介 | NOVELTY - Invention relates to pharmacology, clinical pharmacology and therapy and can be used for correction of protein and lipid status of erythrocytes in ischemic heart disease. Complex therapy is performed for 10 days, wherein daily in the morning at the same time the following are administered: 50 mg of Metoprolol and 8 mg of Perindopril inside, 50 mg/ml Mexicor injections and 2.5 g of Phosphogliv, diluted in 10 ml of injection water, injections, then in the evening at the same time the following components are introduced: 0.5 mg of Nitroglycerine sublingually, 75 mg of Aspirin inside and 2.5 g of Phosphogliv, diluted in 10 ml of injection water, by injection. USE - Pharmaceutics. ADVANTAGE - Invention enables correction of erythrocyte protein and lipid status in ischemic heart disease. 1 cl, 2 dwg, 4 tbl, 4 ex |
| IPC 分类号 | A61K-031/138 ; A61K-031/21 ; A61K-031/4422 ; A61K-031/616 ; A61K-031/683 ; A61P-009/00 |
| 国家 | 俄罗斯 |
| 专业领域 | 化学化工 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/16085 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | UNIV MISIS NAT SCI & TECHNOLOGY (UMNS-C) |
| 推荐引用方式 GB/T 7714 | DOROFEEVA S G,MANSIMOVA O V,POKROVSKII M V,et al. METHOD FOR CORRECTION OF ERYTHROCYTE PROTEIN AND LIPID STATUS IN ISCHEMIC HEART DISEASE. RU2835301-C1[P]. 2024. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论